Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verrica Pharmaceuticals Inc
(NQ:
VRCA
)
0.9900
+0.1000 (+11.24%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Verrica Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Verrica Announces Pricing of $42.0 Million Public Offering
Today 7:30 EST
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Announces Proposed Public Offering
November 20, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
This Super Micro Computer Analyst Turns Bearish; Here Are Top 5 Upgrades For Wednesday
November 06, 2024
Via
Benzinga
Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings
November 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500 Gains 1%; Vimeo Shares Spike Higher
November 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 05, 2024
Via
Benzinga
Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September
November 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 05, 2024
Via
Benzinga
Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
November 05, 2024
Via
Benzinga
Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition
November 04, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
10 Health Care Stocks Moving In Monday's Pre-Market Session
November 04, 2024
Via
Benzinga
Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference
October 24, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA
October 11, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
October 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 03, 2024
Via
Benzinga
This Tractor Supply Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
October 03, 2024
Via
Benzinga
Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
October 02, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA
September 13, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York
September 04, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
August 27, 2024
Via
Benzinga
Crude Oil Down Over 1%; Mercury Systems Shares Spike Higher
August 14, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Jumps Over 200 Points; Performance Food Group Shares Gain After Q4 Results
August 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
VRCA Stock Earnings: Verrica Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
August 14, 2024
VRCA stock results show that Verrica Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
US Stocks Mixed; Inflation Rate Falls More Than Projected
August 14, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Is Dermatology-Focused Verrica Pharmaceuticals Stock Trading Lower On Wednesday?
August 14, 2024
Verrica Pharmaceuticals shares positive preliminary results from Part 2 of its Phase 2 trial for VP-315 in treating basal cell carcinoma, showing promising tumor reduction and safety. No serious...
Via
Benzinga
Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 14, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic Peptide-Based Immunotherapy for the Treatment of Patients with Basal Cell Carcinoma
August 14, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Pharmaceuticals to Report Second Quarter Financial Results and Release Preliminary Topline Results from Part 2 of Phase 2 Trial of VP-315 for the Treatment of Basal Cell Carcinoma on August 14, 2024
August 06, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
7 Short-Squeeze Stocks That Could Beat Down the Bears
July 15, 2024
Panic can be a cruel emotion, especially when the consequences are uncapped red ink.
Via
InvestorPlace
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
July 01, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.